ALDH1A3 and prostate carcinoma: Because ALDH1A3 is expressed higher in prostate cancer than in other cancers, it suggests that it may have some specificity as a diagnostic or prognostic marker for prostate cancer, this specificity helps identify prostate cancer patients, and may be useful for monitoring disease progression or risk of recurrence.